Spiliopoulou, Pavlina and Kazmi, Farasat and Aroldi, Francesca and Holmes, Thomas and Thompson, David and Griffiths, Lucinda and Qi, Cathy and Parkes, Matthew and Lord, Simon and Veal, Gareth J. and Harrison, David J. and Coyle, Vicky M. and Graham, Jill and Jeffry Evans, Thomas R. and Blagden, Sarah P. (2024) A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301). Journal of Experimental and Clinical Cancer Research, 43 (1): 100. ISSN 1756-9966